Cargando…
A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease
Crimean-Congo Hemorrhagic Fever (CCHF) is a severe tick-borne disease, endemic in many countries in Africa, the Middle East, Eastern Europe and Asia. Between 15–70% of reported cases are fatal with no approved vaccine available. In the present study, the attenuated poxvirus vector, Modified Vaccinia...
Autores principales: | Dowall, SD, Buttigieg, KR, Findlay-Wilson, SJD, Rayner, E, Pearson, G, Miloszewska, A, Graham, VA, Carroll, MW, Hewson, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049717/ https://www.ncbi.nlm.nih.gov/pubmed/26309231 http://dx.doi.org/10.1080/21645515.2015.1078045 |
Ejemplares similares
-
A Novel Vaccine against Crimean-Congo Haemorrhagic Fever Protects 100% of Animals against Lethal Challenge in a Mouse Model
por: Buttigieg, Karen R., et al.
Publicado: (2014) -
Intracellular localization of Crimean-Congo Hemorrhagic Fever (CCHF) virus glycoproteins
por: Haferkamp, Sebastian, et al.
Publicado: (2005) -
Thorax CT findings in patients with Crimean-Congo hemorrhagic fever (CCHF)
por: Aktaş, Turan, et al.
Publicado: (2016) -
Epidemics of Crimean-Congo Hemorrhagic Fever (CCHF) in Sudan between 2010 and 2020
por: Ahmed, Ayman, et al.
Publicado: (2022) -
Summer crisis in Iran: increase in reported cases of Crimean-Congo Hemorrhagic Fever (CCHF)
por: Aghamali, Mina, et al.
Publicado: (2017)